Last 30 days
+22.51%
Sep 14 → Oct 22
$32.06
$34.19
$36.33
$38.46
$40.59
Sep 14
Sep 22
Sep 29
Oct 07
Oct 14
Oct 22
GMAB earnings at a glance
Genmab A/S (GMAB) is scheduled to report earnings on Thursday, November 5, 2026 before the market opens — in 13 days. Analysts expect earnings per share of $0.37, compared with $0.65 in the same quarter last year (-43%). The options market is pricing a move of about ±11.9% after the report, a range of roughly $35.23 to $44.77 from today's $40.00. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±4.4% on average; after the most recent report on May 7, 2026 it moved -3.0%. That means options currently expect more movement than GMAB has typically delivered. GMAB beat the consensus EPS estimate in 3 of its last 4 reported quarters. Implied volatility is currently 101%. The share price of $40.00 sits near its 52-week high.
More Health Care stocks · All stocks · Earnings calendar
Overview
Earnings
Financials
Implied Vol
Peers
Overview
52-week range
99% of range
Avg surprise (last 4)
+27.2%
Avg reaction (last 2)
-4.4%
0% positive
Latest IV / EM
101%
EM ±11.9% · $35 · Oct 16
Earnings trends
EPS — actual vs estimate
$0.15 $0.28 $0.40 $0.53 $0.65
Actual $0.31 Est $0.23 Actual $0.54 Est $0.39 Actual $0.65 Est $0.48 Actual $0.15 Est $0.15 Mar/2025 Jun/2025 Sep/2025 Mar/2026
Earnings history
Upcoming
Implied volatility — last 90 days
17% 84% 152% 219% 286%
Jun 07 — IV 53% · EM ±7.4% Jun 11 — IV 50% · EM ±5.5% Jun 12 — IV 57% · EM ±5.8% Jun 16 — IV 253% · EM ±15.0% Jun 19 — IV 91% · EM ±20.2% Jun 22 — IV 58% · EM ±12.1% Jun 23 — IV 94% · EM ±19.3% Jun 24 — IV 67% · EM ±13.4% Jun 25 — IV 73% · EM ±14.3% Jun 26 — IV 100% · EM ±19.1% Jun 29 — IV 101% · EM ±17.9% Jun 30 — IV 119% · EM ±20.6% Jul 01 — IV 121% · EM ±20.3% Jul 02 — IV 96% · EM ±15.6% Jul 03 — IV 100% · EM ±15.6% Jul 06 — IV 115% · EM ±15.9% Jul 07 — IV 72% · EM ±9.5% Jul 08 — IV 46% · EM ±5.8% Jul 14 — IV 65% · EM ±4.7% Jul 20 — IV 72% · EM ±17.1% Jul 21 — IV 89% · EM ±20.6% Jul 22 — IV 65% · EM ±14.8% Jul 23 — IV 41% · EM ±9.3% Jul 24 — IV 53% · EM ±11.7% Jul 27 — IV 64% · EM ±13.3% Jul 28 — IV 51% · EM ±10.5% Jul 29 — IV 60% · EM ±11.9% Jul 30 — IV 70% · EM ±13.8% Jul 31 — IV 59% · EM ±11.3% Aug 03 — IV 72% · EM ±12.8% Aug 04 — IV 85% · EM ±14.6% Aug 05 — IV 73% · EM ±12.1% Aug 06 — IV 65% · EM ±10.5% Aug 07 — IV 66% · EM ±10.2% Aug 10 — IV 51% · EM ±7.1% Aug 11 — IV 40% · EM ±5.3% Aug 12 — IV 55% · EM ±6.9% Aug 13 — IV 51% · EM ±6.1% Aug 14 — IV 130% · EM ±14.4% Aug 17 — IV 65% · EM ±5.4% Aug 18 — IV 210% · EM ±15.2% Aug 20 — IV 287% · EM ±12.0% Aug 24 — IV 46% · EM ±9.5% Aug 25 — IV 49% · EM ±10.1% Aug 26 — IV 54% · EM ±10.7% Aug 27 — IV 46% · EM ±9.0% Aug 28 — IV 44% · EM ±8.4% Aug 31 — IV 37% · EM ±6.5% Sep 01 — IV 17% · EM ±3.0% Sep 02 — IV 27% · EM ±4.5% Sep 03 — IV 47% · EM ±7.6% Sep 04 — IV 64% · EM ±10.0% Sep 07 — IV 73% · EM ±10.0% Sep 08 — IV 64% · EM ±8.4% Sep 09 — IV 110% · EM ±13.8% Sep 10 — IV 100% · EM ±11.8% Sep 11 — IV 117% · EM ±12.9% Sep 14 — IV 176% · EM ±14.7% Sep 21 — IV 50% · EM ±10.4% Sep 22 — IV 47% · EM ±9.7% Sep 23 — IV 52% · EM ±10.4% Sep 24 — IV 64% · EM ±12.6% Sep 25 — IV 49% · EM ±9.3% Sep 28 — IV 54% · EM ±9.6% Sep 29 — IV 78% · EM ±13.4% Sep 30 — IV 68% · EM ±11.4% Oct 01 — IV 61% · EM ±9.8% Oct 02 — IV 66% · EM ±10.4% Oct 06 — IV 86% · EM ±11.4% Oct 07 — IV 105% · EM ±13.1% Oct 08 — IV 101% · EM ±11.9%
GMAB earnings FAQ
When is GMAB's next earnings date? Genmab A/S is expected to report on November 5, 2026, before the market opens.
What is GMAB's expected move for earnings? Options currently price a move of about ±11.9%, or $4.77 per share either way from $40.00.
How does GMAB stock usually react to earnings? Across the last 2 reports the average next-day move was ±4.4%, up 0 times and down 2 times.
What EPS are analysts expecting from Genmab A/S? The consensus estimate is $0.37 per share, versus $0.65 a year ago.
What is GMAB's implied volatility? GMAB's at-the-money implied volatility is about 101% based on the latest options snapshot.